Lung Therapeutics, Inc. Raises $36 Million in Series C Financing

Lung Therapeutics, Inc. Raises $36 Million in Series C Financing

HUGE congrats to member company, Lung Therapeutics, on their $36 Million Series C financing to advance their clinical pipeline. Lung Therapeutics has been a member of ACC Bioscience Incubator since January 2018 and we are so proud of their success. Read more via Yahoo...

New member company, En Solución

En Solución was awarded a 2018 Phase I SBIR grant from the FDA to pursue its research and development. They have joined ACC Bioscience Incubator to improve food safety through development of novel methods for cleaning and sanitizing. Learn more about the company...